Amplicon Sequencing: A Powerful Tool For Precision Genetic Analysis

At Paragon Genomics, we recognize the growing demand for accurate, high-throughput sequencing solutions that support researchers in advancing genetic discovery. Amplicon sequencing stands out as one of the most efficient targeted sequencing methods, providing a streamlined and cost-effective approach to generate high-quality genetic data.

As a comprehensive NGS target enrichment solution, it allows researchers to zoom in on specific genomic regions of interest with precision, speed, and scalability. This makes it an essential tool across multiple domains of precision genetic analysis.

What is Amplicon Sequencing?

Amplicon sequencing is a targeted next-generation sequencing method that focuses on specific genomic regions using PCR amplification. By designing custom primers that flank these target regions, researchers can amplify and sequence multiple loci in parallel. The result is a highly multiplexed, on-target dataset that offers deep coverage, fast turnaround, and high accuracy.

Compared to other targeted sequencing approaches like hybrid capture, amplicon sequencing offers a simpler workflow and greater efficiency. Its naturally high on-target rates stem from precise primer design, which minimizes off-target noise and maximizes usable data. This makes it ideal for applications where accuracy, speed, and cost control are priorities.

Amplicon sequencing also scales well from small panels to thousands of targets, supporting both low-throughput and high-throughput projects with equal effectiveness.

At Paragon Genomics, we offer end-to-end solutions that include CleanPlex NGS amplicon panels designed for optimized performance across a range of applications. Our technology helps researchers achieve reliable and reproducible results with fewer steps and less hands-on time.

Browse Our Store

Applications in Precision Genetic Analysis

Amplicon sequencing supports precision research across a wide range of genetic applications. Its ability to target specific regions with high accuracy and flexibility makes it suitable for clinical, agricultural, and basic science research.

Cancer Genomics

Cancer develops through a series of DNA mutations and gene expression changes that lead to uncontrolled cell growth. Even tumors that share the same histologic type can behave differently depending on their underlying genetic makeup. Amplicon sequencing allows for detailed profiling of these tumor mutations, helping clinicians identify driver variants and guide therapy decisions based on a patient’s specific cancer genetics. By using targeted sequencing panels, researchers can focus on oncogenes, tumor suppressor genes, or even resistance mutations with confidence and efficiency.

Inherited Disorders

Millions of individuals suffer from inherited genetic disorders, many of which manifest early and affect multiple organ systems. Traditional diagnostic approaches relied heavily on clinical observation, but next-generation sequencing has transformed the landscape. Amplicon-based targeted sequencing allows researchers to isolate genes associated with specific disorders, uncover rare or novel variants, and characterize the genetic causes of disease. The fast, easy-to-implement workflow supports both discovery and diagnostic efforts in research labs and clinical settings.

Infectious Disease

Infectious disease research has undergone a shift with the rise of sequencing-based diagnostics. Traditional tools like real-time PCR can detect specific pathogens, but they often lack sensitivity and breadth. Amplicon sequencing enables the detection of multiple pathogens simultaneously, with the added benefit of capturing sequence information that reveals transmission patterns, mutations, and resistance profiles. It also allows for ongoing surveillance and response to emerging threats like new influenza strains, coronaviruses, and antibiotic-resistant bacteria. With its speed and accuracy, amplicon sequencing is a key tool in modern infectious disease control.

Agricultural Genomics

In agriculture, genetic insight drives crop and livestock improvement. Genotyping by sequencing (GBS) helps identify SNPs associated with desired traits, supporting efforts in molecular breeding. Amplicon sequencing serves as a targeted approach within the GBS framework, enabling high-throughput genotyping of thousands of markers with precision. This is especially valuable in complex breeding programs where selection decisions rely on accurate genetic information. As global food systems face increasing pressure, agricultural genomics powered by amplicon sequencing offers a scalable, customizable path forward.

Amplicon Sequencing vs Other NGS Approaches

Amplicon sequencing offers a targeted, efficient approach compared to broader next-generation sequencing methods like hybrid capture, whole-genome sequencing, and whole-exome sequencing. Each of these approaches serves a purpose, but they differ in scope, workflow, and cost.

Whole genome sequencing captures the entire DNA sequence of an organism, providing a complete view but requiring extensive data processing and higher costs. Whole-exome sequencing focuses only on protein-coding regions, offering more focused data but still includes many genes unrelated to a specific study goal.

Hybrid capture methods allow researchers to target broader regions with custom or predesigned probes, but the workflow is more labor-intensive and prone to off-target noise. It also requires longer turnaround times and greater input DNA amounts, which can limit its use with degraded or low-yield samples.

Amplicon sequencing, in contrast, delivers fast, accurate results with higher on-target efficiency and less complexity. Its focused design allows researchers to hone in on the most relevant genes or mutations while keeping the workflow streamlined. This makes it especially valuable in clinical and translational research where speed, specificity, and data clarity matter most.

The primary differences between amplicon sequencing and other approaches include:

  • Covers only specific regions of interest: Reduces sequencing cost and simplifies data analysis
  • Requires less DNA input: Ideal for low-yield or degraded samples
  • Offers fast turnaround times: Supports rapid decision-making in clinical or outbreak settings
  • Generates higher on-target rates: Improves data quality and minimizes background noise
  • Uses simpler workflows: Fewer steps and less hands-on time than hybrid capture

Amplicon sequencing strikes a balance between depth, precision, and scalability, making it a preferred method for focused applications where targeted insights are the goal.

Paragon Genomics’ Amplicon Sequencing Solutions

At Paragon Genomics, our CleanPlex technology meets the growing demand for precise and flexible sequencing tools. Our CleanPlex amplicon-based NGS kits are designed for high performance across a wide range of applications, including infectious disease tracking, precision oncology, inherited disease research, and agricultural genomics.

Researchers can use our CleanPlex Kits for focused genomic testing, full genome amplification, or targeted studies in complex sample types. The technology offers high multiplexing capabilities, exceptional uniformity, and customizable panel design—making it a trusted choice for both established labs and cutting-edge research environments.

Order Paragon Genomics Ready to Use Panels

View NGS Panel Kits
Free Consultation

Learn how CleanPlex NGS panels can accelerate your H5N1 research today.

Enter your email below to schedule a free consultation with our expert scientists to learn how our best-in-class panel can help advance your work.

Related Blog

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research

Overview of Next-Generation Sequencing, Targeted Sequencing and CleanPlex Technology for Precision Medicine and Research Select Options

When the guardian loses function

When the guardian loses function

What is the difference between hybrid capture-based and multiplex PCR-based target enrichment technologies

What is the difference between hybrid capture-based and multiplex PCR-based target enrichment technologies?